MetaCap

Corcept Therapeutics Statistics

NASDAQ: CORTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

63.62-1.36 (-2.09%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Corcept Therapeutics by the numbers

Corcept Therapeutics has a market capitalization of $6.96 billion based on 109.44M shares outstanding. Its trailing P/E ratio is 47.8, and its forward P/E is 12.8. The stock trades 35.8% below its 50-day average and 17.6% below its 200-day average.

Average daily trading volume is 1.26M shares, or about $80.5 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CORT valuation vs. peer median

CORT compared with the median of 8 peer companies
MetricCORTPeer medianDifference
Market cap$6.96B$7.22B-4%
Forward P/E12.835.5-64%
Avg. volume1.26M1.22M+4%

Peer median across 8 companies: CYTK, AXSM, AMRX, KNSA, ABVX, ALKS, MIRM, RYTM.

Valuation

Price / sales (latest FY)
9.14

Price and trading

Previous close
64.98
Open
64.07
Day range
62.81 – 65.13
52-week range
28.66 – 126.38
52-week change
-17.69%
Beta
—
Volume
1.09M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
6.96B
Pe
47.83
Forward Pe
12.77
Eps
1.33
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
126.38
Week52 Low
28.66
Avg Volume
1.26M
Shares Outstanding
109.44M
Ma50
99.03
Ma200
77.18
Earnings Date
Nov 3, 2026
Pct From52w High
-49.66%
Pct From52w Low
121.98%

Related